News & Analysis as of

New Legislation Regulatory Reform Controlled Substances

Ropes & Gray LLP

HALT Fentanyl Act: Unpacking its Significant Reforms for Controlled Substance Research

Ropes & Gray LLP on

On July 16, 2025, President Trump signed the Halt All Lethal Trafficking of Fentanyl (“HALT Fentanyl”) Act into law. The law permanently reclassifies “fentanyl-related substances” into Schedule I of the Controlled Substances...more

Nelson Mullins Riley & Scarborough LLP

Gold Dome Report - Legislative Day 38 - March 2024

Legislative Day 38 provided more healthcare drama than an episode of Grey’s Anatomy. Just hours before the Senate’s committee action deadline on Thursday, a bipartisan group of Senators made a last-minute run at advancing...more

Nelson Mullins Riley & Scarborough LLP

Gold Dome Report - Committee Work Day - February 2024

There may be a calm before most storms, but there certainly isn’t one before Crossover Day in the Georgia General Assembly. Contrary to the popular idiom, House members spent late Tuesday and Wednesday pleading, cajoling,...more

Perkins Coie

Psilocybin: Updates in Oregon and Around the Country

Perkins Coie on

Oregon is the first state in the country to offer controlled use of psilocybin to the public. As we detailed in a prior Update, the state had finalized regulations. Now, the state has licensed its first psilocybin service...more

Robinson+Cole Health Law Diagnosis

Connecticut Legislature Passes Act to Help Address the Opioid Epidemic

On July 6, 2021, Connecticut Governor Ned Lamont signed into law Public Act 21-113 titled “An Act Concerning Opioids” (PA 21-113), which establishes pilot programs to help serve persons with opioid use disorder in urban,...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide